493 related articles for article (PubMed ID: 34366607)
1. Minimally invasive image-guided therapy of primary and metastatic pancreatic cancer.
Bibok A; Kim DW; Malafa M; Kis B
World J Gastroenterol; 2021 Jul; 27(27):4322-4341. PubMed ID: 34366607
[TBL] [Abstract][Full Text] [Related]
2. Ablation of the locally advanced pancreatic cancer: An introduction and brief summary of techniques.
Petrou A; Moris D; Paul Tabet P; David Wensley Richards B; Kourounis G
J BUON; 2016; 21(3):650-8. PubMed ID: 27569086
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous ablation of pancreatic cancer.
D'Onofrio M; Ciaravino V; De Robertis R; Barbi E; Salvia R; Girelli R; Paiella S; Gasparini C; Cardobi N; Bassi C
World J Gastroenterol; 2016 Nov; 22(44):9661-9673. PubMed ID: 27956791
[TBL] [Abstract][Full Text] [Related]
4. Systematic review of innovative ablative therapies for the treatment of locally advanced pancreatic cancer.
Rombouts SJ; Vogel JA; van Santvoort HC; van Lienden KP; van Hillegersberg R; Busch OR; Besselink MG; Molenaar IQ
Br J Surg; 2015 Feb; 102(3):182-93. PubMed ID: 25524417
[TBL] [Abstract][Full Text] [Related]
5. Needle-guided ablation of locally advanced pancreatic cancer: cytoreduction or immunomodulation by in vivo vaccination?
Geboers B; Ruarus AH; Nieuwenhuizen S; Puijk RS; Scheffer HJ; de Gruijl TD; Meijerink MR
Chin Clin Oncol; 2019 Dec; 8(6):61. PubMed ID: 31865711
[TBL] [Abstract][Full Text] [Related]
6. Ablation Strategies for Locally Advanced Pancreatic Cancer.
Linecker M; Pfammatter T; Kambakamba P; DeOliveira ML
Dig Surg; 2016; 33(4):351-9. PubMed ID: 27216160
[TBL] [Abstract][Full Text] [Related]
7. Local ablation of pancreatic tumors: State of the art and future perspectives.
Granata V; Grassi R; Fusco R; Belli A; Palaia R; Carrafiello G; Miele V; Grassi R; Petrillo A; Izzo F
World J Gastroenterol; 2021 Jun; 27(23):3413-3428. PubMed ID: 34163121
[TBL] [Abstract][Full Text] [Related]
8. Comparison of combination therapies in the management of locally advanced pancreatic cancer: Induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation.
He C; Wang J; Zhang Y; Cai Z; Lin X; Li S
Cancer Med; 2020 Jul; 9(13):4699-4710. PubMed ID: 32410380
[TBL] [Abstract][Full Text] [Related]
9. Nonoperative Ablation of Pancreatic Neoplasms.
Marrocchio C; Dababou S; Catalano C; Napoli A
Surg Clin North Am; 2018 Feb; 98(1):127-140. PubMed ID: 29191269
[TBL] [Abstract][Full Text] [Related]
10. Systematic review of novel ablative methods in locally advanced pancreatic cancer.
Keane MG; Bramis K; Pereira SP; Fusai GK
World J Gastroenterol; 2014 Mar; 20(9):2267-78. PubMed ID: 24605026
[TBL] [Abstract][Full Text] [Related]
11. Locally Advanced Pancreatic Cancer: Percutaneous Management Using Ablation, Brachytherapy, Intra-arterial Chemotherapy, and Intra-tumoral Immunotherapy.
Timmer FEF; Geboers B; Nieuwenhuizen S; Schouten EAC; Dijkstra M; de Vries JJJ; van den Tol MP; de Gruijl TD; Scheffer HJ; Meijerink MR
Curr Oncol Rep; 2021 Apr; 23(6):68. PubMed ID: 33864144
[TBL] [Abstract][Full Text] [Related]
12. Locally ablative therapies for primary and metastatic liver cancer.
Li D; Kang J; Madoff DC
Expert Rev Anticancer Ther; 2014 Aug; 14(8):931-45. PubMed ID: 24746315
[TBL] [Abstract][Full Text] [Related]
13. Ablation treatments in unresectable pancreatic cancer.
Paiella S; De Pastena M; Romeo F; D'onofrio M; Fontana M; Pea A; De Marchi G; Crinò SF; Bassi C; Salvia R
Minerva Chir; 2019 Jun; 74(3):263-269. PubMed ID: 30600963
[TBL] [Abstract][Full Text] [Related]
14. Irreversible Electroporation for Locally Advanced Pancreatic Cancer.
Timmer FEF; Geboers B; Ruarus AH; Schouten EAC; Nieuwenhuizen S; Puijk RS; de Vries JJJ; Meijerink MR; Scheffer HJ
Tech Vasc Interv Radiol; 2020 Jun; 23(2):100675. PubMed ID: 32591191
[TBL] [Abstract][Full Text] [Related]
15. Available ablation energies to treat cT1 renal cell cancer: emerging technologies.
Zondervan PJ; Buijs M; De Bruin DM; van Delden OM; Van Lienden KP
World J Urol; 2019 Mar; 37(3):445-455. PubMed ID: 30448873
[TBL] [Abstract][Full Text] [Related]
16. Palliative therapy in pancreatic cancer-interventional treatment with radiofrequency ablation/irreversible electroporation.
Paiella S; De Pastena M; D'Onofrio M; Crinò SF; Pan TL; De Robertis R; Elio G; Martone E; Bassi C; Salvia R
Transl Gastroenterol Hepatol; 2018; 3():80. PubMed ID: 30505967
[TBL] [Abstract][Full Text] [Related]
17. Advanced Pancreatic Cancer: High-Intensity Focused Ultrasound (HIFU) and Other Local Ablative Therapies.
Marinova M; Wilhelm-Buchstab T; Strunk H
Rofo; 2019 Mar; 191(3):216-227. PubMed ID: 30703824
[TBL] [Abstract][Full Text] [Related]
18. Value of CT-Guided Percutaneous Irreversible Electroporation Added to FOLFIRINOX Chemotherapy in Locally Advanced Pancreatic Cancer: A Post Hoc Comparison.
van Veldhuisen E; Vroomen LG; Ruarus AH; Derksen TC; Busch OR; de Jong MC; Kazemier G; Puijk RS; Sorgedrager NS; Vogel JA; Scheffer HJ; van Lienden KP; Wilmink JW; Besselink MG; Meijerink MR
J Vasc Interv Radiol; 2020 Oct; 31(10):1600-1608. PubMed ID: 32861569
[TBL] [Abstract][Full Text] [Related]
19. Irreversible electroporation for locally advanced pancreatic cancer through a minimally invasive surgery supported by laparoscopic ultrasound.
Tartaglia E; Fabozzi M; Rizzuto A; Settembre A; Abete R; Guerriero L; Favoriti P; Cuccurullo D; Corcione F
Int J Surg Case Rep; 2018; 42():290-294. PubMed ID: 29335228
[TBL] [Abstract][Full Text] [Related]
20. An update on locoregional percutaneous treatment technologies in colorectal cancer liver metastatic disease.
Spiliopoulos S; Moschovaki-Zeiger O; Sethi A; Festas G; Reppas L; Filippiadis D; Kelekis N
Expert Rev Med Devices; 2023 Apr; 20(4):293-302. PubMed ID: 36825337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
